• Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Finland France Germany +6

  • Study on the Safety and Effectiveness of Mosunetuzumab and Atezolizumab for Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Germany Spain

  • Study on MAS825 for Patients with Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Italy Spain

  • Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Poland Romania Spain

  • Study on Abrocitinib for Patients with Moderate to Severe Chronic Hand Eczema Unresponsive to Corticosteroids

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study of Chemotherapy and Nivolumab for Patients with Locally Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study of LN-144 and LN-145 (Tumor Infiltrating Lymphocytes) in patients with solid tumors, including melanoma, head and neck cancer, and non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Greece Spain

  • Study of Afamitresgene Autoleucel for Patients with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain

  • Study on Reducing Peripheral Edema in Patients Switching from Amlodipine Besilate to Levamlodipine Succinate

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia

  • Study of PF-07220060 and PF-07104091 with Endocrine Therapy for Patients with Advanced HR-positive HER2-negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Spain

powered by